THALASSEMIAS

Feature

Managing Atrial Fibrillation in Patients With Beta Thalassemia Major

By

Patients with beta thalassemia major may be at higher risk for atrial fibrillation, creating a need for attentive clinical management.

Latest News

Denosumab Promising for Transfusion Dependent Thalassemia-Induced Osteoporosis Treatment

Denosumab may be beneficial for managing transfusion-dependent thalassemia-induced osteoporosis.

Peripheral Blood: An Alternative Source of Stem Cells in Thalassemia

By

Accessing peripheral blood as a graft source is easier and less invasive than accessing bone marrow.

Serum Ferritin May Unreliably Predict Iron Overload in Patients with Thalassemia Major

By

Iron overload that persists after HSCT can cause long-term organ damage.

Hematopoietic Stem Cell Transplant Examined for Inherited Blood Disorder

The researchers found that in transplanted patients, the 30-year overall survival (OS) was 82.6±2.7% and thalassemia-free survival (TFS) was 77.8±2.9% compared with OS of 85.3±2.7% in CT patients (P=NS).

SIGN UP FOR FREE E-NEWSLETTERS